Yoko Shibata Selected Research

Yoko Shibata Research Topics

Disease

21	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 11/2003
9	COVID-19 10/2023 - 02/2021
8	Inflammation (Inflammations) 01/2023 - 11/2005
7	Neoplasms (Cancer) 05/2022 - 01/2010
7	Pneumonia (Pneumonitis) 01/2022 - 01/2011
6	Asthma (Bronchial Asthma) 11/2023 - 05/2016
6	Hypertension (High Blood Pressure) 01/2022 - 04/2009
6	Obesity 01/2022 - 09/2007
6	Infections 07/2021 - 12/2002
6	Albuminuria 08/2016 - 01/2008
5	Pulmonary Emphysema 01/2023 - 05/2008
5	Emphysema 01/2021 - 03/2007
5	Heart Failure 03/2018 - 10/2007
5	Cardiovascular Diseases (Cardiovascular Disease) 02/2018 - 01/2016
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2014
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023 - 09/2018
3	Respiratory Insufficiency (Respiratory Failure) 02/2021 - 03/2018
3	Necrosis 12/2020 - 05/2008
3	Renal Insufficiency (Renal Failure) 01/2015 - 03/2009
3	Body Weight (Weight, Body) 10/2009 - 11/2005
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2024 - 01/2019
2	Clinical Deterioration 10/2023 - 01/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2022 - 12/2018
2	Dermatomyositis (Dermatopolymyositis) 05/2022 - 08/2019
2	Cough 05/2021 - 01/2020
2	Sepsis (Septicemia) 04/2021 - 03/2021
2	Idiopathic Interstitial Pneumonias 03/2020 - 09/2018
2	Connective Tissue Diseases (Connective Tissue Disease) 03/2020 - 01/2013
2	Fibrosis (Cirrhosis) 10/2019 - 12/2003
2	Anemia 10/2019 - 02/2018
2	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2019 - 01/2019
2	Lung Diseases (Lung Disease) 01/2013 - 04/2012
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2013 - 01/2011
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2010 - 08/2009
1	Eosinophilia 11/2023
1	Lymphoma (Lymphomas) 02/2023
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2023
1	Paraproteinemias (Monoclonal Gammopathy) 02/2023
1	Serositis 01/2023
1	Familial Mediterranean Fever (Periodic Disease) 01/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 05/2022
1	Weight Loss (Weight Reduction) 01/2022

Drug/Important Bio-Agent (IBA)

8	SmokeIBA 01/2023 - 03/2007
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2011
6	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 01/2013
6	Oxygen (Dioxygen)IBA 08/2023 - 11/2003
6	AntibodiesIBA 05/2022 - 01/2013
6	CytokinesIBA 02/2021 - 05/2008
6	Fatty Acid Binding Protein 3IBA 03/2018 - 09/2007
5	Proteins (Proteins, Gene)FDA Link 03/2018 - 04/2009
5	AlbuminsIBA 08/2016 - 03/2009
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2022 - 01/2020
4	CreatinineIBA 08/2016 - 10/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 03/2019
3	CC ChemokinesIBA 01/2022 - 01/2008
3	LigandsIBA 01/2022 - 01/2008
3	Pancreatic Elastase (Elastase)IBA 01/2022 - 05/2008
3	AutoantibodiesIBA 03/2020 - 08/2017
3	Messenger RNA (mRNA)IBA 10/2019 - 12/2003
3	CollagenIBA 10/2019 - 01/2016
3	EnzymesIBA 08/2019 - 11/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2016 - 05/2008
3	SodiumIBA 01/2015 - 10/2009
2	Bronchodilator Agents (Bronchodilators)IBA 11/2023 - 05/2016
2	Chemokine CCL17IBA 01/2022 - 01/2021
2	Muscarinic AntagonistsIBA 01/2022 - 05/2016
2	Intravenous Immunoglobulins (IVIG)FDA Link 02/2021 - 03/2018
2	Docetaxel (Taxotere)FDA Link 12/2020 - 01/2010
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2019 - 09/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 01/2010
2	SelectinsIBA 01/2019 - 01/2011
2	Fatty Acid-Binding ProteinsIBA 03/2018 - 02/2018
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2017 - 12/2002
2	Surface-Active Agents (Surfactants)IBA 08/2017 - 04/2012
2	Uric Acid (Urate)IBA 12/2016 - 01/2011
2	MafB Transcription FactorIBA 01/2016 - 01/2013
2	LipopolysaccharidesIBA 01/2016 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 01/2015 - 07/2011
2	AutoantigensIBA 09/2014 - 01/2013
2	ImmunosorbentsIBA 01/2014 - 11/2005
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2011 - 10/2007
2	Phospholipases (Phospholipase)IBA 01/2009 - 11/2005
2	CCAAT-Enhancer-Binding Protein-betaIBA 03/2007 - 10/2006
2	Interferon-gamma (Interferon, gamma)IBA 04/2005 - 12/2002
1	molnupiravirIBA 10/2023
1	Rituximab (Mabthera)FDA Link 02/2023
1	Immunoglobulin A (IgA)IBA 02/2023
1	Factor VIII (Coagulation Factor VIII)IBA 02/2023
1	SecretoglobinsIBA 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	tocilizumab (atlizumab)FDA Link 12/2022
1	transcriptional intermediary factor 1IBA 05/2022
1	AntigensIBA 05/2022
1	Tiotropium Bromide (Spiriva)FDA Link 01/2022
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	4- (3'- (2'- chlorophenyl)- 2'- propen- 1'- ylidene)- 1- phenyl- 3,5- pyrazolidinedioneIBA 01/2022

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 11/2023 - 01/2010
6	Therapeutics 12/2022 - 01/2013
2	Radiotherapy 05/2022 - 01/2011
1	Artificial Respiration (Mechanical Ventilation) 08/2023